Expertise in
8
conditions

John F. Dillon

Mental Health Alcohol And Other Drugs Branch, 
AU 
Expertise in
8
conditions
Mental Health Alcohol And Other Drugs Branch, 
AU 
OverviewLocationsClinical Research

Overview

John Dillon practices in Australia. Mr. Dillon is highly rated in 8 conditions, according to our data. His top areas of expertise are Hepatitis C, Hepatitis, Cirrhosis, and Non-Alcoholic Fatty Liver Disease.

His clinical research consists of co-authoring 200 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Mental Health Alcohol And Other Drugs Branch, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Reaching mEthadone Users Attending Community pHarmacies With HCV
Reaching mEthadone Users Attending Community pHarmacies With HCV
Enrollment Status: Completed
Publish Date: October 13, 2021
Intervention Type: Other
Study Phase: Not Applicable
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: November 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

200 Total Publications

Addressing the utility of a novel score for "At-Risk" MASH in those with significant obesity.
Addressing the utility of a novel score for "At-Risk" MASH in those with significant obesity.
Journal: Hepatology (Baltimore, Md.)
Published: November 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dillon's expertise for a condition
ConditionClose
View All 13 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile